Advertisement
New Zealand markets closed
  • NZX 50

    12,832.55
    +12.27 (+0.10%)
     
  • NZD/USD

    0.6167
    -0.0017 (-0.27%)
     
  • NZD/EUR

    0.5559
    -0.0021 (-0.38%)
     
  • ALL ORDS

    8,323.50
    +30.40 (+0.37%)
     
  • ASX 200

    8,099.90
    +24.20 (+0.30%)
     
  • OIL

    69.93
    +0.96 (+1.39%)
     
  • GOLD

    2,605.70
    +25.10 (+0.97%)
     
  • NASDAQ

    19,504.26
    +81.19 (+0.42%)
     
  • FTSE

    8,280.42
    +39.45 (+0.48%)
     
  • Dow Jones

    41,371.10
    +274.33 (+0.67%)
     
  • DAX

    18,706.65
    +188.26 (+1.02%)
     
  • Hang Seng

    17,369.09
    +128.70 (+0.75%)
     
  • NIKKEI 225

    36,581.76
    -251.51 (-0.68%)
     
  • NZD/JPY

    86.6690
    -0.9990 (-1.14%)
     

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.

Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.

Is This 1 Momentum Stock a Screaming Buy Right Now?

Momentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.

IQVIA Holdings (IQV)

Headquartered in Durham, NC., IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. IQVIA Holdings operates in more than 100 countries, with around 87,000 employees.

IQV sits at a Zacks Rank #3 (Hold), holds a Momentum Style Score of B, and has a VGM Score of B. The stock is down 5% and up 7.6% over the past one-week and four-week period, respectively, and IQVIA Holdings has gained 6.4% in the last one-year period as well. Additionally, an average of 1,274,453.75 shares were traded over the last 20 trading sessions.

Momentum investors don't just pay attention to price changes; positive earnings play a crucial role, too. Eight analysts revised their earnings estimate upwards in the last 60 days for fiscal 2024. The Zacks Consensus Estimate has increased $0.09 to $11.16 per share. IQV boasts an average earnings surprise of 1.8%.

IQV should be on investors' short list because of its impressive earnings fundamentals, a good Zacks Rank, and strong Momentum and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

IQVIA Holdings Inc. (IQV) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research